Advances in Cardiomyocyte and Stem Cell Biology in Heart Disease
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Cardiovascular System".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 745
Special Issue Editor
Interests: muscle physiology; ion channels; protein therapeutics; regenerative medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Heart disease remains a leading cause of mortality and morbidity worldwide, necessitating the continuous exploration of innovative therapeutic approaches. Cardiomyocytes, as the fundamental contractile units of the heart, and stem cells, with their regenerative potential, have emerged as pivotal areas of study in understanding and addressing cardiac pathophysiology. This Special Issue will focus on the latest breakthroughs in cardiomyocyte biology and stem cell research, providing a platform to discuss advances in molecular mechanisms, regenerative strategies, and translational applications.
We welcome original research articles, reviews, and that highlight novel insights into cardiomyocyte function, the role of ion channels, protein therapeutics, and advancements in regenerative medicine. By bridging fundamental biology and clinical potential, this collection of papers will accelerate the development of effective treatments for heart disease. Contributions on innovative cell-based therapies, bioengineering approaches, and emerging biophysical tools are especially encouraged.
Dr. Ki Ho Park
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiomyocytes
- stem cells
- heart disease
- regenerative medicine
- ion channels
- protein therapeutics
- bioengineering
- molecular biology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
